Financial Times FT.com

Resources

Future of stem cells

Future of stem cells 2005

The future of stem cells is one of the most important issues in modern science. It is also a critical matter for public policy. This special report - a collaboration between the FT and Scientific American - is the first comprehensive guide to the subject for the non-scientist. - -

Content

From the editors

Stem cells have moved from biological obscurity to the forefront of political and technological debate in the US and around the world.

Mother of All Cells

Scientists expect enormous benefits for humankind from the surge of research on embryonic stem cells. But it could take a generation or two before the full impact is felt.

Human-animal chimeras

Stem cell science has become notorious for obliging society to consider again where it draws the line between human embryonic cells and human beings.

Dirty & dying, but US approved?

In August 2001 when President Bush forbade the creation of new embryonic stem cell lines with federal money.

Cloning connection

Stem cell scientists are often irritated by the way people confuse their work with cloning, even though cloning plays no part in most ES cell research today.

Repair workers within

Adult stem cells may escape the ethical controversies of their embryonic counterparts, but as Christine Soares notes, their practical clinical value is far more murky.

Patient, heal thyself

The body’s innate capacity for regeneration is what all stem cell therapies strive to emulate and improve upon.

Making stem cells on demand

What can a simple newt do that humans are trying to learn?

A patchwork of laws

Richard Gardner and Tim Watson find much disagreement around the world about what should be allowed with stem cells-in spite of attempts at finding consensus.

The next frontier: The courtroom

As arguments mount over who will own the future technologies born of stem cell research, corporate lawyers prepare for battle.

Engineering aside the morality

A world of approaches to stem cells

Country report: China

Country report: United Kingdom

The California gambit

Scientists follow the money

The ghost of Lysenko

Growing pains for the new industry

Tough cell to investors

The search for cells that heal